| Item Number | Description | Schedule Fee |
|---|---|---|
| 61565 | Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. (R) |
$953.00 |
| Total: | $953.00 | |